Vyome Holdings, Inc. (HIND)
2.09
+0.06
(+2.96%)
USD |
NASDAQ |
Oct 09, 16:00
Vyome Holdings Gross Profit Margin (Quarterly) : 33.33% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.33% |
| March 31, 2026 | 44.30% |
| December 31, 2025 | 53.01% |
| September 30, 2025 | 43.93% |
| June 30, 2025 | 42.60% |
| March 31, 2025 | 75.98% |
| December 31, 2024 | |
| September 30, 2024 | 38.70% |
| June 30, 2024 | 57.71% |
| March 31, 2024 | 59.93% |
| December 31, 2023 | 92.94% |
| September 30, 2023 | 59.77% |
| June 30, 2023 | 52.97% |
| March 31, 2023 | 53.52% |
| December 31, 2022 | 51.45% |
| September 30, 2022 | 75.09% |
| June 30, 2022 | 65.11% |
| March 31, 2022 | 49.92% |
| December 31, 2021 | 56.52% |
| September 30, 2021 | 57.58% |
| Date | Value |
|---|---|
| June 30, 2021 | 61.01% |
| March 31, 2021 | 70.91% |
| December 31, 2020 | 51.17% |
| September 30, 2020 | 63.33% |
| June 30, 2020 | 49.18% |
| March 31, 2020 | 30.64% |
| December 31, 2019 | 20.33% |
| September 30, 2019 | -23.72% |
| June 30, 2019 | -62.18% |
| March 31, 2019 | 30.59% |
| December 31, 2018 | 26.13% |
| September 30, 2018 | 52.53% |
| June 30, 2018 | 36.60% |
| March 31, 2018 | 42.87% |
| December 31, 2017 | 53.90% |
| September 30, 2017 | 52.85% |
| June 30, 2017 | 49.57% |
| March 31, 2017 | 44.09% |
| December 31, 2016 | -12.82% |
| September 30, 2016 | 16.69% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Cardiac Biotech Solutions, Inc. | 0.00% |
| Anika Therapeutics, Inc. | 65.15% |
| Enovis Corp. | 54.51% |
| Edwards Lifesciences Corp. | 78.09% |
| Perspective Therapeutics, Inc. | -1.31K% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -200.6% |
| Return on Assets | -138.1% |
| Return on Invested Capital | -199.1% |
| Profit Margin (Quarterly) | -2.67K% |
| Operating Margin (Quarterly) | -3.19K% |
| Return on Net Operating Assets | -736.0% |